Paul Schneider
Director of Finance/CFO bij FREELINE THERAPEUTICS HOLDINGS PLC
Actieve functies van Paul Schneider
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
FREELINE THERAPEUTICS HOLDINGS PLC | Director of Finance/CFO | 16-05-2022 | - |
Director/Board Member | 04-04-2023 | 20-02-2024 |
Loopbaan van Paul Schneider
Eerdere bekende functies van Paul Schneider
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Casebia Therapeutics LLC
Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC is a joint venture company that focuses on discovering, developing, and commercializing gene-editing therapeutics to treat genetic causes of bleeding disorders and autoimmune diseases. The company is based in Cambridge, MA. | Corporate Officer/Principal | 01-07-2016 | 01-09-2019 |
Exo Therapeutics, Inc.
Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Exo Therapeutics, Inc. engages in production of drugs. It has developed a small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes (exo-sites) that are not evolutionarily conserved. The company was founded by David R. Liu and Alan Saghatelian and is headquartered in Boston, MA. | Chief Operating Officer | - | - |
Director of Finance/CFO | - | - |
Opleiding van Paul Schneider
Boston College | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 4 |
Verenigd Koninkrijk | 2 |
Operationeel
Director of Finance/CFO | 2 |
Director/Board Member | 1 |
Chief Operating Officer | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Casebia Therapeutics LLC
Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC is a joint venture company that focuses on discovering, developing, and commercializing gene-editing therapeutics to treat genetic causes of bleeding disorders and autoimmune diseases. The company is based in Cambridge, MA. | Health Technology |
Exo Therapeutics, Inc.
Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Exo Therapeutics, Inc. engages in production of drugs. It has developed a small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes (exo-sites) that are not evolutionarily conserved. The company was founded by David R. Liu and Alan Saghatelian and is headquartered in Boston, MA. | Health Technology |
Freeline Therapeutics Holdings Plc
Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
- Beurs
- Insiders
- Paul Schneider
- Ervaring